Review




Structured Review

Galectin Therapeutics galectin 3 positive puncta
Galectin 3 Positive Puncta, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/10__1097_slash_hep__0000000000001718-178-12-12
Average 86 stars, based on 1 article reviews
galectin 3 positive puncta - by Bioz Stars, 2026-10
86/100 stars

Images

Related Articles

Permeability:

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the .

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [55].

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [ ].

Article Title: Laponite Lights Calcium Flickers by Reprogramming Lysosomes to Steer DC Migration for An Effective Antiviral CD8 + T‐Cell Response
Article Snippet: Given that LPO can greatly affect the fluidity and permeability of the membrane structure, the lysosomal membrane permeability (LMP) was further analyzed using acridine orange (AO) staining (Figure ) and galectin‐3 (LGALS3) puncta assay (Figure , Supporting information).

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the SM (Figure S5 in Section S4.6).

Article Title: Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy.
Article Snippet: Nanotechnology has proven its enormous application value in clinical practice.. However, current research on nanomedicines mainly focuses on developing nanoparticles as delivery carriers to maximize the bioavailability of therapeutic agents, with little attention on exploring their potential to directly regulate physiological processes.. In this study, inspired by the lysosomal swelling caused by excessive accumulation of undegraded substances, this work presents a lysosomal-targeting aggregated nanoparticle (LTANP) for cancer treatment.

Article Title: Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Article Snippet: Aims: Chronic kidney disease (CKD) and subsequent hyperphosphatemia causes vascular calcification (VC), a strong predictor of mortality.. Dysregulation of the autophagy-lysosomal pathway in vascular smooth muscle cells (VSMCs) mediates hyperphosphatemia-dependent VC.. However, the process through which lysosomes become dysfunctional remains unknown.

Membrane:

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the .

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [55].

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [ ].

Article Title: Laponite Lights Calcium Flickers by Reprogramming Lysosomes to Steer DC Migration for An Effective Antiviral CD8 + T‐Cell Response
Article Snippet: Given that LPO can greatly affect the fluidity and permeability of the membrane structure, the lysosomal membrane permeability (LMP) was further analyzed using acridine orange (AO) staining (Figure ) and galectin‐3 (LGALS3) puncta assay (Figure , Supporting information).

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the SM (Figure S5 in Section S4.6).

Article Title: Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy.
Article Snippet: Nanotechnology has proven its enormous application value in clinical practice.. However, current research on nanomedicines mainly focuses on developing nanoparticles as delivery carriers to maximize the bioavailability of therapeutic agents, with little attention on exploring their potential to directly regulate physiological processes.. In this study, inspired by the lysosomal swelling caused by excessive accumulation of undegraded substances, this work presents a lysosomal-targeting aggregated nanoparticle (LTANP) for cancer treatment.

Article Title: Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Article Snippet: Aims: Chronic kidney disease (CKD) and subsequent hyperphosphatemia causes vascular calcification (VC), a strong predictor of mortality.. Dysregulation of the autophagy-lysosomal pathway in vascular smooth muscle cells (VSMCs) mediates hyperphosphatemia-dependent VC.. However, the process through which lysosomes become dysfunctional remains unknown.

Staining:

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the .

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [55].

Article Title: Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
Article Snippet: The potential effect of the hybrids on the lysosomes was investigated by a Galectin-3 puncta assay, which is a reliable tool to detect LMP [ ].

Article Title: Laponite Lights Calcium Flickers by Reprogramming Lysosomes to Steer DC Migration for An Effective Antiviral CD8 + T‐Cell Response
Article Snippet: Given that LPO can greatly affect the fluidity and permeability of the membrane structure, the lysosomal membrane permeability (LMP) was further analyzed using acridine orange (AO) staining (Figure ) and galectin‐3 (LGALS3) puncta assay (Figure , Supporting information).

Article Title: Novel Erlotinib-Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms.
Article Snippet: Hybrids were not able to induce LMP in HNSCC cells according to the Galectin-3 puncta assay as demonstrated by confocal images outlined in the SM (Figure S5 in Section S4.6).

Article Title: Lysosome Targeted Nanoparticle Aggregation Reverses Immunosuppressive Tumor Microenvironment for Cancer Immunotherapy.
Article Snippet: Nanotechnology has proven its enormous application value in clinical practice.. However, current research on nanomedicines mainly focuses on developing nanoparticles as delivery carriers to maximize the bioavailability of therapeutic agents, with little attention on exploring their potential to directly regulate physiological processes.. In this study, inspired by the lysosomal swelling caused by excessive accumulation of undegraded substances, this work presents a lysosomal-targeting aggregated nanoparticle (LTANP) for cancer treatment.

Article Title: Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.
Article Snippet: Aims: Chronic kidney disease (CKD) and subsequent hyperphosphatemia causes vascular calcification (VC), a strong predictor of mortality.. Dysregulation of the autophagy-lysosomal pathway in vascular smooth muscle cells (VSMCs) mediates hyperphosphatemia-dependent VC.. However, the process through which lysosomes become dysfunctional remains unknown.



Similar Products

86
Galectin Therapeutics galectin 3 positive puncta
Galectin 3 Positive Puncta, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/10__1097_slash_hep__0000000000001718-178-12-12
Average 86 stars, based on 1 article reviews
galectin 3 positive puncta - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics lgals3 galectin 3 puncta
Lgals3 Galectin 3 Puncta, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/lgals3/pm41612597-114-9-10
Average 86 stars, based on 1 article reviews
lgals3 galectin 3 puncta - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 puncta
Galectin 3 Puncta, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/lgals3/pmc11652224-650-12-12
Average 86 stars, based on 1 article reviews
galectin 3 puncta - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics f galectin 3 puncta assay
F Galectin 3 Puncta Assay, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/lgals3/pmc12577261-43-0-1
Average 86 stars, based on 1 article reviews
f galectin 3 puncta assay - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Galectin Therapeutics galectin 3 gfp puncta
Galectin 3 Gfp Puncta, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/galectin-3+puncta+assay/lgals3/pm41073412-130-9-9
Average 86 stars, based on 1 article reviews
galectin 3 gfp puncta - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results